Toxoplasma chorioretinitis
ICD-10 B58.2 is a billable code used to indicate a diagnosis of toxoplasma chorioretinitis.
Toxoplasma chorioretinitis is an ocular manifestation of Toxoplasma gondii infection, a protozoan parasite that can cause significant morbidity, particularly in immunocompromised individuals and during pregnancy. The condition is characterized by inflammation of the choroid and retina, leading to symptoms such as blurred vision, floaters, and in severe cases, vision loss. The infection is often acquired through ingestion of oocysts found in contaminated food or water, or through contact with cat feces. In immunocompetent individuals, the infection may be asymptomatic or present mild flu-like symptoms, but in those with weakened immune systems, such as HIV/AIDS patients, it can lead to severe ocular complications. Diagnosis typically involves clinical examination, serological tests for Toxoplasma antibodies, and imaging studies like fundus photography or OCT (Optical Coherence Tomography). Treatment usually includes antiparasitic medications such as pyrimethamine and sulfadiazine, often combined with corticosteroids to reduce inflammation. Early diagnosis and treatment are crucial to prevent irreversible damage to the retina and preserve vision.
Detailed ocular examination findings, imaging results, and treatment plans.
Patients presenting with vision changes, floaters, or diagnosed with HIV/AIDS.
Ensure documentation reflects the severity of the condition and any associated systemic symptoms.
Comprehensive patient history, serological test results, and treatment response.
Immunocompromised patients with suspected or confirmed Toxoplasma infections.
Document any co-infections and the patient's overall immune status.
Used for follow-up visits in patients diagnosed with Toxoplasma chorioretinitis.
Document visual acuity, fundoscopic findings, and treatment response.
Ophthalmologists should ensure comprehensive documentation of ocular health.
Common symptoms include blurred vision, floaters, and in severe cases, vision loss. Patients may also experience eye pain and redness.